Comments
Loading...

AstraZeneca

AZNNASDAQ
$75.85
-3.86-4.84%
Pre-Market: 8:37 AM EDT
15 minutes delayed
Q2 2024 earnings were released today before the market open
Today's conference call ended over 6 hours ago Click to view the webcast
Consensus Rating1
Buy
Highest Price Target1
$97.00
Lowest Price Target1
$75.00
Consensus Price Target1
$83.83

AstraZeneca (NASDAQ:AZN) Stock, Analyst Ratings, Price Targets, Forecasts

AstraZeneca PLC has a consensus price target of $83.83 based on the ratings of 11 analysts. The high is $97 issued by Goldman Sachs on May 30, 2024. The low is $75 issued by Argus Research on August 29, 2022. The 3 most-recent analyst ratings were released by Argus Research, Goldman Sachs, and BMO Capital on May 30, 2024, May 30, 2024, and April 26, 2024, respectively. With an average price target of $88 between Argus Research, Goldman Sachs, and BMO Capital, there's an implied 16.02% upside for AstraZeneca PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
1
Apr
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Argus Research
Goldman Sachs
BMO Capital
Morgan Stanley
SVB Leerink

1calculated from analyst ratings

Analyst Ratings for AstraZeneca

Buy NowGet Alert
05/30/2024Buy Now12.06%Argus Research
Jasper Hellweg
$80 → $85MaintainsBuyGet Alert
05/30/2024Buy Now27.88%Goldman Sachs
Rajan Sharma
→ $97Initiates → BuyGet Alert
04/26/2024Buy Now8.11%BMO Capital
Etzer Darout
$80 → $82MaintainsOutperformGet Alert
04/16/2024Buy NowDeutsche Bank
Emmanuel Papada
UpgradeSell → HoldGet Alert
02/12/2024Buy Now5.47%BMO Capital
Etzer Darout
$82 → $80MaintainsOutperformGet Alert
02/08/2024Buy NowDeutsche Bank
Emmanuel Papadakis
DowngradeBuy → HoldGet Alert
01/23/2024Buy Now12.06%Morgan Stanley
Mark Purcell
→ $85Initiates → OverweightGet Alert
01/03/2024Buy NowJefferies
Peter Welford
DowngradeBuy → HoldGet Alert
09/25/2023Buy Now5.47%Jefferies
Peter Welford
$66.5 → $80UpgradeHold → BuyGet Alert
09/08/2023Buy NowErste GroupDowngradeBuy → HoldGet Alert
08/01/2023Buy Now9.43%BMO Capital
Etzer Darout
$81 → $83MaintainsOutperformGet Alert
05/26/2023Buy Now5.47%Argus Research
Jasper Hellweg
$85 → $80MaintainsBuyGet Alert
04/13/2023Buy Now12.06%Argus Research
Jasper Hellweg
$75 → $85MaintainsBuyGet Alert
01/05/2023Buy Now8.11%BMO Capital
Etzer Darout
→ $82Initiates → OutperformGet Alert
11/14/2022Buy Now4.15%SVB Leerink
Andrew Berens
$78 → $79MaintainsOutperformGet Alert
11/11/2022Buy Now2.83%SVB Leerink
Andrew Berens
$75 → $78MaintainsOutperformGet Alert
08/29/2022Buy Now-1.12%Argus Research
John Eade
→ $75UpgradeHold → BuyGet Alert
05/04/2022Buy Now-1.12%SVB Leerink
Andrew Berens
$70 → $75MaintainsOutperformGet Alert
02/24/2022Buy Now-7.71%SVB Leerink
Andrew Berens
$65 → $70MaintainsOutperformGet Alert
02/11/2022Buy NowDZ Bank
Elmar Kraus
UpgradeSell → HoldGet Alert
12/07/2021Buy NowJefferies
Peter Welford
DowngradeBuy → HoldGet Alert
09/27/2021Buy Now-3.76%SVB Leerink
Andrew Berens
MaintainsOutperformGet Alert
09/20/2021Buy Now-6.39%SVB Leerink
Andrew Berens
MaintainsOutperformGet Alert
08/04/2021Buy Now-9.03%SVB Leerink
Andrew Berens
MaintainsOutperformGet Alert

FAQ

Q

What is the target price for AstraZeneca (AZN) stock?

A

The latest price target for AstraZeneca (NASDAQ:AZN) was reported by Argus Research on May 30, 2024. The analyst firm set a price target for $85.00 expecting AZN to rise to within 12 months (a possible 12.06% upside). 11 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for AstraZeneca (AZN)?

A

The latest analyst rating for AstraZeneca (NASDAQ:AZN) was provided by Argus Research, and AstraZeneca maintained their buy rating.

Q

When was the last upgrade for AstraZeneca (AZN)?

A

The last upgrade for AstraZeneca PLC happened on April 16, 2024 when Deutsche Bank raised their price target to N/A. Deutsche Bank previously had a sell for AstraZeneca PLC.

Q

When was the last downgrade for AstraZeneca (AZN)?

A

The last downgrade for AstraZeneca PLC happened on February 8, 2024 when Deutsche Bank changed their price target from N/A to N/A for AstraZeneca PLC.

Q

When is the next analyst rating going to be posted or updated for AstraZeneca (AZN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AstraZeneca, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AstraZeneca was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.

Q

Is the Analyst Rating AstraZeneca (AZN) correct?

A

While ratings are subjective and will change, the latest AstraZeneca (AZN) rating was a maintained with a price target of $80.00 to $85.00. The current price AstraZeneca (AZN) is trading at is $75.85, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch